• Something wrong with this record ?

Patient perspectives on the acceptability of mHealth technology for remote measurement and management of epilepsy: A qualitative analysis

SK. Simblett, E. Bruno, S. Siddi, F. Matcham, L. Giuliano, JH. López, A. Biondi, H. Curtis, J. Ferrão, A. Polhemus, M. Zappia, A. Callen, P. Gamble, T. Wykes, RADAR-CNS Consortium,

. 2019 ; 97 (-) : 123-129. [pub] 20190624

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

BACKGROUND: Innovative uses of mobile health (mHealth) technology for real-time measurement and management of epilepsy may improve the care provided to patients. For instance, seizure detection and quantifying related problems will have an impact on quality of life and improve clinical management for people experiencing frequent and uncontrolled seizures. Engaging patients with mHealth technology is essential, but little is known about patient perspectives on their acceptability. The aim of this study was to conduct an in-depth qualitative analysis of what people with uncontrolled epilepsy think could be the potential uses of mHealth technology and to identify early potential barriers and facilitators to engagement in three European countries. METHOD: Twenty people currently experiencing epileptic seizures took part in five focus groups held across the UK, Italy, and Spain. Participants all completed written consent and a demographic questionnaire prior to the focus group commencing, and each group discussion lasted 60-120 min. A coding frame, developed from a systematic review of the previous literature, was used to structure a thematic analysis. We extracted themes and subthemes from the discussions, focusing first on possible uses of mHealth and then the barriers and facilitators to engagement. RESULTS: Participants were interested in mHealth technology as a clinical detection tool, e.g., to aid communication about seizure occurrence with their doctors. Other suggested uses included being able to predict or prevent seizures, and to improve self-management. Key facilitators to engagement were the ability to raise awareness, plan activities better, and improve safety. Key barriers were the potential for increased stigma and anxiety. Using familiar and customizable products could be important moderators of engagement. CONCLUSION: People with uncontrolled epilepsy think that there is a scope for mHealth technology to be useful in healthcare as a detection or prediction tool. The costs will be compared with the benefits when it comes to engagement, and ongoing work with patients and other stakeholders is needed to design practical resources.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20025734
003      
CZ-PrNML
005      
20201222155405.0
007      
ta
008      
201125s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.yebeh.2019.05.035 $2 doi
035    __
$a (PubMed)31247523
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Simblett, Sara K $u Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK. Electronic address: sara.simblett@kcl.ac.uk.
245    10
$a Patient perspectives on the acceptability of mHealth technology for remote measurement and management of epilepsy: A qualitative analysis / $c SK. Simblett, E. Bruno, S. Siddi, F. Matcham, L. Giuliano, JH. López, A. Biondi, H. Curtis, J. Ferrão, A. Polhemus, M. Zappia, A. Callen, P. Gamble, T. Wykes, RADAR-CNS Consortium,
520    9_
$a BACKGROUND: Innovative uses of mobile health (mHealth) technology for real-time measurement and management of epilepsy may improve the care provided to patients. For instance, seizure detection and quantifying related problems will have an impact on quality of life and improve clinical management for people experiencing frequent and uncontrolled seizures. Engaging patients with mHealth technology is essential, but little is known about patient perspectives on their acceptability. The aim of this study was to conduct an in-depth qualitative analysis of what people with uncontrolled epilepsy think could be the potential uses of mHealth technology and to identify early potential barriers and facilitators to engagement in three European countries. METHOD: Twenty people currently experiencing epileptic seizures took part in five focus groups held across the UK, Italy, and Spain. Participants all completed written consent and a demographic questionnaire prior to the focus group commencing, and each group discussion lasted 60-120 min. A coding frame, developed from a systematic review of the previous literature, was used to structure a thematic analysis. We extracted themes and subthemes from the discussions, focusing first on possible uses of mHealth and then the barriers and facilitators to engagement. RESULTS: Participants were interested in mHealth technology as a clinical detection tool, e.g., to aid communication about seizure occurrence with their doctors. Other suggested uses included being able to predict or prevent seizures, and to improve self-management. Key facilitators to engagement were the ability to raise awareness, plan activities better, and improve safety. Key barriers were the potential for increased stigma and anxiety. Using familiar and customizable products could be important moderators of engagement. CONCLUSION: People with uncontrolled epilepsy think that there is a scope for mHealth technology to be useful in healthcare as a detection or prediction tool. The costs will be compared with the benefits when it comes to engagement, and ongoing work with patients and other stakeholders is needed to design practical resources.
650    _2
$a dospělí $7 D000328
650    _2
$a postoj ke zdraví $7 D001294
650    12
$a komunikace $7 D003142
650    _2
$a management nemoci $7 D019468
650    _2
$a epilepsie $x terapie $7 D004827
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a zjišťování skupinových postojů $7 D017144
650    _2
$a zakotvená teorie $7 D066296
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a pacientův souhlas se zdravotní péčí $7 D010342
650    _2
$a zapojení pacienta $7 D010358
650    12
$a vztahy mezi lékařem a pacientem $7 D010817
650    _2
$a kvalita života $7 D011788
650    _2
$a záchvaty $7 D012640
650    12
$a self-management $7 D000073278
650    12
$a telemedicína $7 D017216
650    _2
$a mladý dospělý $7 D055815
651    _2
$a Itálie $7 D007558
651    _2
$a Španělsko $7 D013030
651    _2
$a Spojené království $7 D006113
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bruno, Elisa $u Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
700    1_
$a Siddi, Sara $u Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Centro de Investigació Biomedica en Red CIBERSAM, Spain; University of Barcelona, Barcelona, Spain.
700    1_
$a Matcham, Faith $u Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
700    1_
$a Giuliano, Loretta $u Department of Medical and Surgical Sciences and Advanced Technologies "G.F. Ingrassia", Section of Neurosciences, University of Catania, Catania, Italy.
700    1_
$a López, Jorge Hortas $u QITERIA Investigación Social Aplicada, Madrid, Spain.
700    1_
$a Biondi, Andrea $u Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
700    1_
$a Curtis, Hannah $u Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
700    1_
$a Ferrão, José $u MSD Czech Republic, Prague, Czech Republic.
700    1_
$a Polhemus, Ashley $u MSD Czech Republic, Prague, Czech Republic.
700    1_
$a Zappia, Mario $u Department of Medical and Surgical Sciences and Advanced Technologies "G.F. Ingrassia", Section of Neurosciences, University of Catania, Catania, Italy.
700    1_
$a Callen, Antonio $u Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Centro de Investigació Biomedica en Red CIBERSAM, Spain; University of Barcelona, Barcelona, Spain.
700    1_
$a Gamble, Peter $u MSD Czech Republic, Prague, Czech Republic.
700    1_
$a Wykes, Til $u Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK; NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust, King's College London, UK.
710    2_
$a RADAR-CNS Consortium
773    0_
$w MED00005701 $t Epilepsy & behavior : E&B $x 1525-5069 $g Roč. 97, č. - (2019), s. 123-129
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31247523 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222155401 $b ABA008
999    __
$a ok $b bmc $g 1599879 $s 1116420
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 97 $c - $d 123-129 $e 20190624 $i 1525-5069 $m Epilepsy & behavior $n Epilepsy Behav $x MED00005701
LZP    __
$a Pubmed-20201125

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...